Editas Medicine (EDIT) Reports Q4 Loss of $0.52/Share

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.52), versus ($0.84) reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth